Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Target Axillary Dissection After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer

NCT05763641 is registered in ClinicalTrials.gov with Hospital Universitari de Bellvitge as lead sponsor.

NCT NCT05763641
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05763641 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Target Axillary Dissection After Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
Lead sponsor
Hospital Universitari de Bellvitge
Phase
Observational
Overall status
Recruiting
Start date
February 1, 2021
Completion date
June 1, 2027
Enrollment
162 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, locally advanced, sentinel lymph node